Patent Assignment
Reel/Frame 046803/0950
Assignment of Assignor's Interest
Recorded: 2018-08-14
Pages: 5
Assignor
HORIZON PHARMA SERVICES LIMITED
Executed: 2018-08-14
Assignee
HORIZON PHARMA IRELAND LIMITED
CONNAUGHT HOUSE, 1ST FLOOR, 1 BURLINGTON ROAD, DUBLIN 4, IRELAND
Covered Property
(1)
METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
May 7, 2015
From: HORIZON PHARMA SERVICES LIMITED (FORMERLY AGI THERAPEUTICS LIMITED)
To: CITIBANK, N.A.
Reel/Frame 035590/0889 →
Change of Name
Aug 12, 2015
From: AGI THERAPEUTICS LIMITED
To: HORIZON PHARMA SERVICES LIMITED
Reel/Frame 036309/0553 →
Release of Security Interest
Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS IRELAND DAC (SUCCESSOR IN INTEREST TO HORIZON PHARMA SERVICES LIMITED); HORIZON THERAPEUTICS IRELAND DAC (FKA HORIZON PHARMA IRELAND LIMITED); HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.); HZNP LIMITED
Reel/Frame 065153/0953 →